Inflammatory Arthritis Due to Immune Checkpoint Inhibitors: Challenges in Diagnosis and Treatment
Open Access
- 21 December 2016
- journal article
- Published by Taylor & Francis in Immunotherapy
- Vol. 9 (1) , 5-8
Abstract
No abstract availableKeywords
Funding Information
- Jerome L Greene Foundation Scholar Award and the National Institute of Arthritis
- Musculoskeletal and Skin Diseases (P30-AR053503; K23-AR061439)
This publication has 28 references indexed in Scilit:
- Nivolumab in Previously Untreated Melanoma withoutBRAFMutationNew England Journal of Medicine, 2015
- Arthritis and Tenosynovitis Associated With the Anti-PD1 Antibody Pembrolizumab in Metastatic MelanomaJournal of Immunotherapy, 2015
- Anti-programmed-death-receptor-1 treatment with pembrolizumab in ipilimumab-refractory advanced melanoma: a randomised dose-comparison cohort of a phase 1 trialThe Lancet, 2014
- Advances in the management of psoriatic arthritisNature Reviews Rheumatology, 2014
- Pituitary Expression of CTLA-4 Mediates Hypophysitis Secondary to Administration of CTLA-4 Blocking AntibodyScience Translational Medicine, 2014
- Management of Immune-Related Adverse Events and Kinetics of Response With IpilimumabJournal of Clinical Oncology, 2012
- Ipilimumab plus Dacarbazine for Previously Untreated Metastatic MelanomaNew England Journal of Medicine, 2011
- Solid malignancies among etanercept‐treated patients with granulomatosis with polyangiitis (Wegener's): Long‐term followup of a multicenter longitudinal cohortArthritis & Rheumatism, 2011
- Enterocolitis in Patients With Cancer After Antibody Blockade of Cytotoxic T-Lymphocyte–Associated Antigen 4Journal of Clinical Oncology, 2006
- New radiographic bone erosions in the wrists of patients with rheumatoid arthritis are detectable with magnetic resonance imaging a median of two years earlierArthritis & Rheumatism, 2003